Edesa Biotech, Inc. (EDSA)

Edesa Biotech Balance Sheet

Financials in millions USD. Fiscal year is October - September.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2025	Sep 30, 2024	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021
Cash & Equivalents	10.79	1.04	5.36	7.09	7.84
Cash & Short-Term Investments	10.79	1.04	5.36	7.09	7.84
Cash Growth	940.39%	-80.65%	-24.39%	-9.55%	8.67%
Other Receivables	0.64	0.27	0.63	1.26	3.3
Receivables	0.64	0.27	0.63	1.26	3.3
Prepaid Expenses	0.08	0.37	0.45	0.75	0.95
Total Current Assets	11.51	1.68	6.44	9.09	12.09
Property, Plant & Equipment	-	0.02	0.1	0.03	0.11
Other Intangible Assets	1.98	2.08	2.18	2.28	2.38
Other Long-Term Assets	0.04	0.04	0.17	0.17	-
Total Assets	13.53	3.81	8.89	11.58	14.58
Accounts Payable	1.08	1.81	1.75	2.12	1.38
Current Portion of Leases	-	0.02	0.07	0.02	0.08
Total Current Liabilities	1.08	1.83	1.82	2.14	1.46
Long-Term Leases	-	-	0.02	-	0.02
Other Long-Term Liabilities	-	-	-	0.04	0.05
Total Liabilities	1.08	1.83	1.84	2.18	1.53
Common Stock	54.52	47.24	46.64	42.47	34.89
Additional Paid-In Capital	14.75	13.58	13.04	11.18	4.87
Retained Earnings	-65.91	-58.59	-52.42	-44.04	-26.5
Comprehensive Income & Other	-0.17	-0.24	-0.21	-0.21	-0.21
Total Common Equity	3.19	1.98	7.05	9.39	13.06
Shareholders' Equity	12.45	1.98	7.05	9.39	13.06
Total Liabilities & Equity	13.53	3.81	8.89	11.58	14.58
Total Debt	-	0.02	0.09	0.02	0.1
Net Cash (Debt)	10.79	1.02	5.27	7.07	7.74
Net Cash Growth	960.70%	-80.68%	-25.52%	-8.63%	9.79%
Net Cash Per Share	1.90	0.32	1.84	3.37	4.49
Filing Date Shares Outstanding	8.33	3.47	3.16	2.76	1.93
Total Common Shares Outstanding	7.14	3.25	3.08	2.38	1.9
Working Capital	10.43	-0.16	4.61	6.95	10.63
Book Value Per Share	0.45	0.61	2.29	3.95	6.88
Tangible Book Value	1.21	-0.1	4.87	7.11	10.68
Tangible Book Value Per Share	0.17	-0.03	1.58	2.99	5.62
Machinery	-	-	0.05	0.05	0.05

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q